Office of Portfolio Analysis

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article's use of external links may not follow Wikipedia's policies or guidelines. Please improve this article by removing excessive or inappropriate external links, and converting useful links where appropriate into footnote references. (August 2020) (Learn how and when to remove this message) This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citations to reliable, independent, third-party sources. (August 2020) (Learn how and when to remove this message) (Learn how and when to remove this message)

The Office of Portfolio Analysis was established in the Division of Program Coordination, Planning, and Strategic Initiatives in 2011 to assist NIH Institutes and Centers with scientific portfolio analysis.^[1] Per the Federal Register, the Office of Portfolio Analysis serves the following goals:

1. Prepare and analyze data on NIH sponsored biomedical research to inform trans-NIH planning and coordination;
2. Serve as a resource for portfolio management at the programmatic level;
3. Employ databases, analytic tools, methodologies and other resources to conduct assessments in support of portfolio analyses and priority setting in scientific areas of interest across NIH;
4. Research and develop new analytic tools, support systems, and specifications for new resources in coordination with other NIH organizations to enhance the management of the NIH's scientific portfolio; and
5. Provide, in coordination with other NIH organizations, training on portfolio analysis tools, procedures, and methodology.

After its establishment in 2011, George Santangelo was appointed as the first Director of the Office of Portfolio Analysis.